Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 3 dokumen yang sesuai dengan query
cover
Weny Yusnita
Abstrak :
ABSTRAK
Latar belakang: Fibroadenoma dan tumor filodes jinak merupakan tumor fibroepitelial dengan gambaran histopatologik yang tumpang tindih. Saat ini banyak pengambilan jaringan tumor payudara secara core biopsy, termasuk pada tumor fibroepitelial. Jumlah jaringan yang sedikit dan gambaran histopatologik yang tumpang tindih sering menyulitkan Dokter Spesialis Patologi Anatomik dalam menentukan diagnosis fibroadenoma dan tumor filodes jinak. Penelitian ini bertujuan untuk mengetahui gambaran histopatologik apa saja yang bermakna untuk mendiagnosis fibroadenoma dan tumor filodes jinak dan untuk menguji apakah diagnosis fibroadenoma dan tumor filodes jinak pada core biopsy dengan menggunakan sistem skoring lebih baik dibandingan tanpa skoring. Bahan dan cara: Penelitian ini merupakan suatu uji diagnostik. 57 kasus fibroadenoma dan tumor filodes jinak yang memiliki slaid core biopsy dan mastektomi/lumpektomi/eksisi dinilai ulang tanpa sistem skoring dan menggunakan skoring. Gambaran histopatologik yang dinilai pada sistem skoring adalah selularitas stroma, atipia inti, fragmentasi jaringan, infiltrasi lemak, mitosis dan heterogenitas stroma. Kemudian dilakukan analisis statistik, uji diagnostik dan uji kappa. Hasil: Selularitas stroma, heterogenitas stroma dan fragmentasi jaringan lebih sering ditemukan pada tumor filodes jinak dan berbeda bermakna (p=0,001; p=0,000; p=0,021). Spesifisitas pada sistem skoring meningkat sebesar 17,9%. Nilai duga positif dan nilai duga negatif pada sistem skoring meningkat sebesar 11,9% dan 5,1%. Area under curve (AUC) meningkat 8,9%. Uji Cohen?s kappa antara diagnosis core biopsy tanpa dan dengan skoring bernilai rendah (0,545). Kesimpulan: Adanya peningkatan spesifisitas, nilai duga positif dan AUC menunjukkan bahwa penilaian core biopsy sistem skoring lebih baik dibandingkan tanpa skoring dan dapat menjadi acuan untuk diagnosis fibroadenoma dan tumor filodes jinak. ABSTRACT
Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.

Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.

Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by 17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).

Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.;Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.

Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.

Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by 17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).

Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.;Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.

Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.

Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by 17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).

Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.;Background: Fibroadenoma and benign phyllodes tumor are kinds of fibroepithelial tumor which have overlapping histopathological features. Recently, core biopsy is commonly performed to determine breast tumor, including fibroepithelial tumor. Small amount of tissue and overlapped histopathological features often complicate the Pathologist in diagnosing both. This study aims to describe the histopathological appearance which needed to diagnose fibroadenoma and benign phyllodes tumor and to verify if the diagnosis of fibroadenoma and benign phyllodes tumor in core biopsy using scoring system is more accurate than without scoring system.

Method: This study was a diagnostic test, in which 57 cases of fibroadenoma and benign phyllodes tumor which had undergone core biopsy and mastectomy/excision were re-assessed using and without using scoring system. Histopathologic features which assessed using scoring system were stromal cellularity, nuclear atypia, tissue fragmentation, fat infiltration, mitotic figure, stromal heterogeneity. Analytical statistic, diagnostic test, accuracy test and Kappa test were done.

Results: Stromal cellularity, stromal heterogeneity and tissue fragmentation mostly found in benign phyllodes tumor and significantly different (p=0,001; p=0,000; p=0,021).There were significant differences between stromal cellularity (p=0,001), stromal heterogeneity (p=0,000), and tissue fragmentation (p=0,021) in diagnosis of benign phyllodes tumor. Specificity in scoring system increased by 17,9 %. Positive predictive value, negative predictive value and accuracy increased in scoring system (11,9% and 5,1%). Area under curve (AUC) increased by 8,9%. Cohen's Kappa test between core biopsy diagnosis without using and using scoring system had low result(0,545).

Conclusion: The increasing of specificity, positive predictive value, accuracy and AUC proved that core biopsy with scoring system is more accurate than without scoring. This can be used as reference to diagnose fibroadenoma and benign phyllodes tumor.
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Chandra Dewi Kartika Setyaningsih
Abstrak :
ABSTRAK
Latar Belakang : Karsinoma kolorektal (KKR) merupakan penyebab kematian kedua di dunia dari seluruh jenis kanker. KKR dapat disebabkan oleh defek dari MMR DNA. Microsatellite instability (MSI) adalah penanda defek MMR DNA. KKR MSI-H memiliki gambaran karakteristik tertentu. Tumor-infiltrating-lymphocyte (TIL) merupakan faktor prognosis. Hilangnya ekspresi PMS2 dan MSH6 dapat sebagai penanda MSI. Penelitian ini bertujuan untuk menilai terjadinya MSI pada KKR di sisi kiri dan sisi kanan kolon melalui Hilangnya ekspresi PMS2 dan MSH6, serta mengetahui hubungan antara TIL dengan MSI-H. Bahan dan Metode : Dilakukan pulasan IHK PMS2 dan MSH6, serta penghitungan TIL. Penilaian dilakukan dengan menghitung hilangnya ekspresi PMS2 dan MSH6 pada inti sel dan dikelompokkan ke dalam kelompok mutasi dan tidak mutasi .Penghitungan TIL juga dikelompokkan ke dalam TIL tinggi dan rendah, berdasarkan nilai titik potong Hasil : Didapatkan 27,8% kasus menunjukkan hilangnya ekspresi PMS2 dan MSH6 dengan 14,4% kasus di distal kolon. TIL terbanyak di distal kolon 30% kasus. Tidak terdapat perbedaan bermakna antara mutasi PMS2 dan MSH6 dengan lokasi (p=0,829) dan TIL (p=0,187). Terdapat perbedaan bermakna antara usia dan lokasi (p=0,020) serta peningkatan ekspresi PMS2 dengan MSH6 (p=0,06). Kesimpulan : MSI-H ditemukan pada 27,8% kasus. Penggunaan PMS2 dan MSH6 pada penelitian ini belum dapat menggantikan 4 panel IHK. Terdapat kecenderungan dimana adenokarsinoma NOS memiliki frekuensi mutasi lebih tinggi dari adenokarsinoma musinosum. ABSTRACT
Background : Colorectal carcinoma (CRC) is the world second leading cause of death from all types of cancer. CRC can be caused by a defect of MMR DNA. Microsatellite instability (MSI) is a marker of DNA MMR defect. CRC MSI-H has a certain characteristic figures. Tumor-infiltrating lymphocytes (TIL) isone of prognostic factor. Loss expression of the PMS2 and MSH6 can be use as a marker of MSI. This study aims to assess the occurrence of MSI in CRC on the left side and the right side of the colon through the loss of expression of PMS2 and MSH6, and determine the relationship between TIL with MSI-H. Materials and Methods : Immunohistochemical staining using two marker, there is PMS2 and MSH6. We also counting the number of TIL. Assessment by calculating the loss expression of PMS2 and MSH6 in the cell nuclei and divided into two groups, the mutations and non mutations . TIL result also grouped into high and low, based on the cutoff point. Result : There are 27.8% of cases showed loss of expression of PMS 2 and MSH6 with 14.4% of cases in the distal colon. About 30% TIL cases located in distal colon. There were no significant differences between PMS2 and MSH6 mutation with the location (p = 0.829) and TIL (p = 0.187). There are significant differences between age and location (p = 0.020) and increased expression of PMS2 with MSH6 (p = 0.06). \ Conclusion : MSI-H was found in 27.8% of cases. The use of PMS2 and MSH6 in this study have not been able to replace 4 panels of IHC. There is a tendency where the adenocarcinoma NOS have a higher mutation frequency than mucinous adenocarcinoma. ;Background : Colorectal carcinoma (CRC) is the world second leading cause of death from all types of cancer. CRC can be caused by a defect of MMR DNA. Microsatellite instability (MSI) is a marker of DNA MMR defect. CRC MSI-H has a certain characteristic figures. Tumor-infiltrating lymphocytes (TIL) isone of prognostic factor. Loss expression of the PMS2 and MSH6 can be use as a marker of MSI. This study aims to assess the occurrence of MSI in CRC on the left side and the right side of the colon through the loss of expression of PMS2 and MSH6, and determine the relationship between TIL with MSI-H. Materials and Methods : Immunohistochemical staining using two marker, there is PMS2 and MSH6. We also counting the number of TIL. Assessment by calculating the loss expression of PMS2 and MSH6 in the cell nuclei and divided into two groups, the mutations and non mutations . TIL result also grouped into high and low, based on the cutoff point. Result : There are 27.8% of cases showed loss of expression of PMS 2 and MSH6 with 14.4% of cases in the distal colon. About 30% TIL cases located in distal colon. There were no significant differences between PMS2 and MSH6 mutation with the location (p = 0.829) and TIL (p = 0.187). There are significant differences between age and location (p = 0.020) and increased expression of PMS2 with MSH6 (p = 0.06). \ Conclusion : MSI-H was found in 27.8% of cases. The use of PMS2 and MSH6 in this study have not been able to replace 4 panels of IHC. There is a tendency where the adenocarcinoma NOS have a higher mutation frequency than mucinous adenocarcinoma. ;Background : Colorectal carcinoma (CRC) is the world second leading cause of death from all types of cancer. CRC can be caused by a defect of MMR DNA. Microsatellite instability (MSI) is a marker of DNA MMR defect. CRC MSI-H has a certain characteristic figures. Tumor-infiltrating lymphocytes (TIL) isone of prognostic factor. Loss expression of the PMS2 and MSH6 can be use as a marker of MSI. This study aims to assess the occurrence of MSI in CRC on the left side and the right side of the colon through the loss of expression of PMS2 and MSH6, and determine the relationship between TIL with MSI-H. Materials and Methods : Immunohistochemical staining using two marker, there is PMS2 and MSH6. We also counting the number of TIL. Assessment by calculating the loss expression of PMS2 and MSH6 in the cell nuclei and divided into two groups, the mutations and non mutations . TIL result also grouped into high and low, based on the cutoff point. Result : There are 27.8% of cases showed loss of expression of PMS 2 and MSH6 with 14.4% of cases in the distal colon. About 30% TIL cases located in distal colon. There were no significant differences between PMS2 and MSH6 mutation with the location (p = 0.829) and TIL (p = 0.187). There are significant differences between age and location (p = 0.020) and increased expression of PMS2 with MSH6 (p = 0.06). \ Conclusion : MSI-H was found in 27.8% of cases. The use of PMS2 and MSH6 in this study have not been able to replace 4 panels of IHC. There is a tendency where the adenocarcinoma NOS have a higher mutation frequency than mucinous adenocarcinoma.
Depok: Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Retno Widyawati
Abstrak :
ABSTRAK
Latar belakang: Endometriosis merupakan kelainan ginekologik yang paling sering ditemukan. Seperti halnya endometrium di uterus juga dapat terjadi berbagai perubahan pada epitel yang melapisi kista endometriosis di ovarium, antara lain metaplasia, hiperplasia, atipia bahkan perubahan ke arah keganasan. Saat ini banyak penelitian yang menghubungkan antara endometriosis dan kanker ovarium terutama jenis clear cell dan dikenal dengan istilah endometriosisassociated ovarian carcinoma (EAOC) dan dilaporkan adanya mutasi yang menginaktifkan gen supresor tumor (ARID1A), sehingga protein BAF250a tidak diekpresikan pada Clear cell carcinoma (CCC) ovarii. Bahan dan cara: Dilakukan pulasan imunohistokimia ARID1A pada sampel 20 kasus endometriosis non atipik, 20 kasus atipik dan 20 kasus CCC ovarii tahun 2012 hingga Maret 2015. Dari kelompok kasus CCC didapatkan 9 kasus EAOC. Selanjutnya dilihat adakah perbedaan persentase ekspresi ARID1A pada endometriosis non atipik, atipik, CCC ovarii serta endometriosis disertai CCC (EAOC). Hasil: Pada kelompok kasus endometriosis non atipik, atipik dan CCC ada perbedaan bermakna persentase ekspresi ARID1A (uji Kruskal-Wallis p=0,0035). Selanjutnya dilakukan analisis Post Hoc uji Mann-Whitney dan didapatkan perbedaan bermakna persentase ekspresi ARID1A antara endometriosis non atipik dan atipik dengan CCC ovarii (p=0,001 dan p=0,0015). Pada kelompok kasus endometriosis non atipik, atipik dan endometriosis pada EAOC, didapatkan ada perbedaan bermakna persentase ekspresi ARID1A (Uji Kruskal-Walis p=0,011). Selanjutnya dilakukan analisis Post Hoc uji Mann-Whitney dan ada perbedaan bermakna persentase ekspresi ARID1A antara endometriosis non atipik dan atipik dengan EAOC (p=0,005 dan p=0,008). Kesimpulan: Ekspresi ARID1A pada endometriosis non atipik dan atipik lebih tinggi bermakna dibanding CCC ovarii dan EAOC. Sehingga ekspresi ARID1A kemungkinan dapat digunakan sebagai petanda adanya transformasi ganas pada endometriosis. ABSTRACT
Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis. ;Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis. ;Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis. ;Background: Endometriosis is one of the most common gynecological abnormalities found. Endometriosis cyst in the ovary also exhibited changes in epithelial cyst just like endometrium in the uterus. Changes in the epithelial cells also include metaplasia, hyperplasia, atyphia even changes toward malignan characteristics. Nowadays, there are some research that linked endometriosis and clear cell ovarian cancer which is known with endometriosis-associated ovarian carcinoma (EAOC) it is reported that there?s a mutation that activated tumor suppressor gene (ARID1A), so protein BAF250a is not expressed in Clear Cell Carcinoma (CCC) in the ovarium. Materials and Methods: Immunohistochemistry staining of ARID1A were done in 20 samples of non-atypical endometriosis, 20 samples of atypical endometriosis, 20 samples of CCC in the ovarium from the year 2012 until march 2015. From the group that experienced CCC we get 9 cases of EAOC. After that, we see if there?s any difference in the percentage of ARID1A expression in nonatypical endometrosis, atypical endometriosis, CCC in the ovarium and endometriosis with CCC( EAOC). Results: In non-atypical endometriosis, atypical and CCC cases groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,0035). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with CCC (p=0,001 and p=0,0015). In non-atypical endometriosis, atypical and EAOC groups there are significant differences on the percentage of ARID1A expression (Kruskal-Walis test p=0,011). Post Hoc analysis were done using Mann-Whitney test and there are significant differences on ARID1A expression between non-atypical and atypical endometriosis with EAOC (p=0,005 and p=0,008). Conclusion: Expression of ARID1A in non atypical and atypical endometriosis are significantly higher compared to ovarian CCC and EAOC. So, we can say that ARID1A may be used as a marker for malignancy transformation in endometriosis.
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library